Mr. Speaker, in our opinion, the current regulatory framework adequately blocks the use of bovine somatotropin in Canada. The example mentioned by the hon. member is a minor exception.
I am aware of the hon. member's concerns, but, up to now, they have been unfounded. We will continue investigating and, if we detect any problems, we will take the appropriate action.